Relative dose intensity and therapy efficacy in different breast cancer molecular subtypes: a retrospective study of early stage breast cancer patients treated with neoadjuvant chemotherapy
Jiaqi Yuan(Soochow University), Feiyu Chen(Cancer Institute (WIA)), Zhi Xiao(Shanghai University of Traditional Chinese Medicine), Shou-Man Wang(Central South University), Jian Hai(Tongji University), Jie Mao(Novogene Bioinformatics Institute), Ke-jing Zhang(Central South University), Shayang Luo(Central South University), Lei Guo(Qingdao University), Yan Li(Hebei General Hospital), Na Luo(Central South University), Liqiu Liao(Central South University), Yuhui Wu(First Affiliated Hospital of Xiamen University), OU Hui-ying(Central South University), Li–li Tang(Central South University), Jun Huang(Central South University)
Cited by 27
Related Papers
The MicroRNA-328 Regulates Hypoxic Pulmonary Hypertension by Targeting at Insulin Growth Factor 1 Receptor and L-Type Calcium Channel-α1C
|Hypertension|2012|133
Long-term Survival after Combined Epidural–General Anesthesia or General Anesthesia Alone: Follow-up of a Randomized Trial
|Anesthesiology|2021|76
The long non‐coding RNA DANCR regulates the inflammatory phenotype of breast cancer cells and promotes breast cancer progression <i>via</i> EZH2‐dependent suppression of SOCS3 transcription
|Molecular Oncology|2019|72
Inhibition of excessive autophagy and mitophagy mediates neuroprotective effects of URB597 against chronic cerebral hypoperfusion
|Cell Death and Disease|2018|64
EIF2A promotes cell survival during paclitaxel treatment in vitro and in vivo
|Journal of Cellular and Molecular Medicine|2019|64